Annual EBITDA
-$1.00 M
NaN%
December 31, 2021
Summary
- As of February 10, 2025, IBER annual EBITDA is -$1.00 million
Performance
IBER EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$233.60 K
-$93.10 K-66.26%
September 30, 2022
Summary
- As of February 10, 2025, IBER quarterly EBITDA is -$233.60 thousand, with the most recent change of -$93.10 thousand (-66.26%) on September 30, 2022.
- Over the past year, IBER quarterly EBITDA has increased by +$81.90 thousand (+25.96%).
Performance
IBER Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$1.04 M
+$81.90 K+7.32%
September 30, 2022
Summary
- As of February 10, 2025, IBER TTM EBITDA is -$1.04 million, with the most recent change of +$81.90 thousand (+7.32%) on September 30, 2022.
- Over the past year, IBER TTM EBITDA has dropped by -$393.30 thousand (-61.09%).
Performance
IBER TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
IBER EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +26.0% | -61.1% |
| 3 y3 years | - | -147.2% | -997.5% |
| 5 y5 years | - | -147.2% | -997.5% |
IBER EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +66.3% | +54.3% | +3.3% | +16.9% |
| 5 y | 5-year | at high | at low | +147.2% | +54.3% | +997.5% | +16.9% |
| alltime | all time | at high | at low | +147.2% | +54.3% | +997.5% | +16.9% |
Ibere Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$233.60 K(+66.3%) | -$1.04 M(-7.3%) |
| Jun 2022 | - | -$140.50 K(-53.6%) | -$1.12 M(-7.7%) |
| Mar 2022 | - | -$302.60 K(-16.0%) | -$1.21 M(+20.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.00 M | -$360.40 K(+14.2%) | -$1.00 M(+56.0%) |
| Sep 2021 | - | -$315.50 K(+34.9%) | -$643.80 K(+96.1%) |
| Jun 2021 | - | -$233.80 K(+147.4%) | -$328.30 K(+247.4%) |
| Mar 2021 | - | -$94.50 K | -$94.50 K |
FAQ
- What is Ibere Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Ibere Pharmaceuticals?
- What is Ibere Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Ibere Pharmaceuticals?
- What is Ibere Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Ibere Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Ibere Pharmaceuticals?
- What is Ibere Pharmaceuticals TTM EBITDA year-on-year change?
What is Ibere Pharmaceuticals annual EBITDA?
The current annual EBITDA of IBER is -$1.00 M
What is the all time high annual EBITDA for Ibere Pharmaceuticals?
Ibere Pharmaceuticals all-time high annual EBITDA is -$1.00 M
What is Ibere Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of IBER is -$233.60 K
What is the all time high quarterly EBITDA for Ibere Pharmaceuticals?
Ibere Pharmaceuticals all-time high quarterly EBITDA is -$94.50 K
What is Ibere Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, IBER quarterly EBITDA has changed by +$81.90 K (+25.96%)
What is Ibere Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of IBER is -$1.04 M
What is the all time high TTM EBITDA for Ibere Pharmaceuticals?
Ibere Pharmaceuticals all-time high TTM EBITDA is -$94.50 K
What is Ibere Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, IBER TTM EBITDA has changed by -$393.30 K (-61.09%)